Whale HuntersThe areas marked are the zones whales hunt within ... they seek liquidity in these zones and don't like remaining within them for very long ! While they appear in likeness to FVG , they are fairly different . These zones act like walls , on either side lay lots of buy and sell orders which remain in place.
These zones are where whales buy/sell and if you identify these zones they can help you add confluence to your TA without getting harmed in the way of a whale fight. Look to these zones for a reaction and that will provide you with a good idea of where PA will go . The price either strongly rejects or flies through these zones so you must ensure you watch market structure.
Along with confluence for entry , these zones may also be a good point to seek profit. Price likes to sit between these zones so if you would like to swing trade , these zones are the preferable place to take profit !
As these zones continue to grow or shrink i will update this chart - you do not want to ignore these opportunities !
-Oz
Buyzone
UMBF breaking out of an 11 month base!* Great earnings
* Strong up trend
* High 3-month relative strength in the Financial sector
* Breaking out of a ~11 month base with higher than average volume
* Originally broke out last month but due to the market conditions it had a very slight pull back
* During the pull back it held up very well relative to the general market conditions.
* Maximum probable ROI is ~24.16% if the trade goes in our favor
Trade Idea:
* This is another breakout attempt after the general market is showing signs of recovery.
* Now's a great time to enter as the price is very close to the broken resistance and it's EMA's
* Weekly chart is also showing signs of the price being ready to move higher.
OMCL showing signs of moving higher with a pocket pivot?* Great earnings
* Strong up trend
* Very high 3-month relative strength in the Healthcare sector of 10.44
* Trading at higher than average volume creating a pocket pivot
* Trading in a tight range of ~5% range
* Little to no overhead resistance
* Has held up incredibly well during this correction with little to no downside at all.
Trade Idea:
* You can enter as indicated before the breakout from the range.
* This entry will net you a better risk/reward ratio but with the risk of not breaking out just yet.
* If you want to be conservative given the current market conditions, it may be better to wait for the breakout (a daily close) above $182.73 before entering.
Note/Caution:
* This is a pocket pivot entry and although it has little to no resistance, it may not break out immediately.
* Pocket pivots indicate institutional interest in the stock.
ZIM ready to go higher?* Relatively new company
* 3 out of 4 earning reports were great
* Strong up trend
* High 3-month relative strength in the Industrial sector
* Pays dividends very generously
* Increase in institutional interest
* Breaking out of a 15 week base forming a cup and handle pattern
* Depth of the cup is ~24.8%
* Breaking out with higher than the 15 day average volume
* $57.54 should serve as support moving forward
Trade Idea:
* Now's a great time to enter as the markets seem to be recovering and the sector seems to be doing well also.
* The price is very close to the broken level
ODFL offering another great entry before the next leg higher!* Great earnings
* Very strong up trend
* High 3-month relative strength in the Industrial sector
* I last mentioned ODFL when it was about to break out from $304.22 and it has since then moved higher.
* Even as the industrial sector was hit hard in the past week ODFL managed to consolidate maintaining its volume.
* This indicates that institutions are very interested in this stock.
* If the market is rebounding now, we can expect ODFL to continue higher.
Trade Idea:
* Now's a great time to enter as it's bouncing off of support but hasn't moved too far up.
* If you're looking for a slight discount you may look for an entry near the $349.21 area.
Ethereum Classic (ETC) Buy ZoneEthereum Classic (ETC) Buy Zone
--------------------
BIAS
Mid-Term : Bullish
Long-Term : Bullish
Now that we’ve seen a cool down in price action, Ethereum Classic has seen a ~10% drop towards $45.5 where it found strong support.
--------------------
$ETC/USDT SPOT SETUP
Entry Price : 44.65 - 46.6
TP 1 : 50.6
TP 2 : 54.5
TP 3 : 58.1
TP 4 : 62.3
TP 5 : 70.25
TP 6 : 76.35
TP 7 : 86
TP 8 : 99
SL : 39.45
*Maximum 5% of Portfolio.
*Unload 12.5% at each TP. Whenever TP 2 hits, Move stop loss to entry.
--------------------
AJG finally looking to move higher?* Great earnings
* Very strong up trend
* High 3-month relative strength in the Financial sector
* Breaking out of a tight range of ~3.35% with slightly higher than average volume
* I originally mentioned this as it was breaking out of the cup with handle pattern at $153.09
* It has since then move higher and then started to consolidate
* Even as the financial sector took a hit in the past week AJG managed to consolidate and stay afloat
* This shows that there are institutions still interested in this stock and are holding it up
* Now as the markets are showing signs of recovery, AJG is breaking out of the consolidation
Trade Idea:
* Now's a great time to enter as the price is just above the broken resistance of the range
SGH using IPO base resistance as support!* Great accelerating earnings
* Breaking out of its IPO base
* High 3-month relative strength in the Tech sector
* Using the broken resistance of the IPO base as support
* Formed a cup and handle pattern
* Holding up really well even in a correction
* Has been consolidating right above broken resistance for the past 4 weeks.
* Maximum probable ROI is ~41%
* Depth of the base is at ~70%
* Has been forming the base since 2018 so ~70% move up isn't unlikely
Trade Idea:
* Given the nature of the current market and if you don't mind a little volatility, now would be a great time to enter as it's constructing a new support around the $56.69 area.
* If you're looking for a slight discount you can look for an entry around the $56.69 area given it's acting as support
Caution:
* A daily close below $56.69 would negate the idea.
* Given the market conditions and your risk tolerance use your judgement as to where you should enter.
* A daily close below $56.69 could have the price around $53.73
TER ready to move higher after using the 2000 highs as support?* Exceptional earnings
* Strong up trend
* High 3-month relative strength in the Tech sector
* Breaking out of a ~1 year base with higher than average volume
* Recently used $104.88 as support which was the high from the 2000's
* Broke base resistance ($147.46) and has been using it as support for the past
12 days
* Maximum probable ROI would be ~41.84%
Trade Idea:
* Great time to enter as the price is bouncing off of the broken resistance and isn't too far away.
* If you're looking for a slight discount you can look for an entry near the $147.46 area since that should serve as support moving forward.
UDR ready to move higher?* Great earnings
* Very strong up trend
* High 3-month relative strength in the Real Estate sector
* Breaking out of a 18 week base with higher than average volume
* Has been consolidating above the broken resistance for the past 12 days making it a new level of support.
Trade Idea:
* Now's a great time to enter as the Real Estate market is showing strength.
* Price isn't too far away from the broken resistance turned support
* If you're looking for a slight discount you can look for buying opportunities near the $55.93 area
UNI goes for $28Uniswap is probably preparing to use the Polygon blockchain and it will be huge.
Uni has recently broken its downtrend. But now isn't a good time to buy (Risky)
There is a possibility of Pool-Back to the green zone and that's a good opportunity to enter.
Dear Friends, Always consider that not losing is better than not gaining. There will also always be good opportunities, so never get involved with FOMO.
Good Time
NUM - 10x ~ 100x PotentialThis project presents a real and practical product that I think if they work well in its development, it can be among the top 150 in the less than 1 year.
Dears, ofc I just introduced it (#DYOR)
Consider that Binance is paying attention to this project!
Their Website
Good Time
CUBE ready to move higher?* Great earnings
* Very strong up trend
* High 3-month relative strength in the Real Estate sector
* Breaking out of a ~2 month base forming a cup and handle
* Breaking out with higher than average volume
Trade Idea:
* Now's a great time to enter as the price is very close to the broken level
* Looking at the weekly chart, it seems like this is ready to move now.
Caution:
* Consider exiting the trade if it makes a daily close below $54.56 and makes lower lows for 3 consecutive days
MAA showing strength in the Real Estate sector.* Good earnings
* Very strong up trend
* High 3-month relative strength in the Real Estate sector
* Breaking out of a base on base pattern
* The upper base was constructed over 6 weeks
* Breaking out with a lot of volume (130.2% above the 15 day average)
* The Real Estate sector has been consolidating in a very tight range for the past several weeks and is showing signs of breaking out.
Trade Idea:
* Now's a good time to enter as the price broke out for the second time in 3 days.
* It broke out with tonnes of volume so I expect $207.69 to serve as support moving forward
* Alternatively, if you're not getting in now, you can look for buying opportunities near the support of $207.69.
Caution:
* Needless to say, the market is very volatile at the moment and if this makes a daily close below the 20 EMA you might want to consider taking an early exit.
$PTN entry PT .70-.75 Target PT 1.59 Long term PT 5 and higher$PTN H.C. Wainwright analyst Joseph Pantginis is behind today’s news as he reiterated the firm’s buy rating for PTN stock. To go along with that, Pantginis also increased the price target for PTN stock from $2 per share to $5 per share, 1,371% upside
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.
IOTX USD Buy SOON (Under .2000)I've marked some important numbers for IOTX. I think this crypto looks good until .5333. With a quick BTC pullback, it could bring this coin down a tiny bit, which could allow for some significant movement to the upside.
My sell points are marked in orange. My buy points are marked in green. I wouldn't like to see this go any lower than .1800
$BNTX^ $BNTX will announce if its possible to revise their current vaccine to accommodate the new strain in 2 weeks and could redesign its vaccine within 6 weeks, with an aim to distribute it within 100 days.
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small cell lung cancer.It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody, which is in Phase I/IIa clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.